2017
DOI: 10.3389/fcimb.2017.00222
|View full text |Cite
|
Sign up to set email alerts
|

Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 60 publications
0
14
0
Order By: Relevance
“…Regulating DC differentiation and function may be a potential strategy for ticks to promote blood-feeding and pathogen transmission. More effort is being done to study the critical roles of biologically important tick bioactive molecules in tick-pathogen-hosts [3436]. RHcyst-1 may be a promising target for tick control in the future.…”
Section: Discussionmentioning
confidence: 99%
“…Regulating DC differentiation and function may be a potential strategy for ticks to promote blood-feeding and pathogen transmission. More effort is being done to study the critical roles of biologically important tick bioactive molecules in tick-pathogen-hosts [3436]. RHcyst-1 may be a promising target for tick control in the future.…”
Section: Discussionmentioning
confidence: 99%
“…Similar protein families are found in ixodid and argasid ticks, and in Nuttalliella namaqua, suggesting they were present in the ancestral tick lineage (Mans et al, 2016). Reviews on the discovery of proteins in tick saliva and their characterisation include: Steen et al, 2006;Murfin and Fikrig, 2017;Šimo et al, 2017. Many studies involve tick feeding on laboratory hosts that the particular tick species would not encounter naturally, hence limiting interpretation of the results as host species affects expression of saliva proteins and feeding success (Wang et al, 2001b;Anderson et al, 2017;Tirloni et al, 2017).…”
Section: Composition Of Tick Salivamentioning
confidence: 99%
“…Lipocalins are promising new therapy candidates based on their natural ligand-binding functions to store and transport small compounds, which together with their structure (small polypeptide chain) led to design of artificial binding proteins “anticalins” with novel specificities, for example as transporters for pharmaceuticals. In general, it is a very long way from basic research to translation to the clinical praxis and, according to Murfin and Fikrig (2017), with many gaps and lacks. It is known that arthropod molecules are unstable, have a short half-life (for example OmCI mentioned in this review) or are cytotoxic, thus they require improved pharmacokinetics, optimization of dosage, delivery way, etc.…”
Section: Resultsmentioning
confidence: 99%
“…Ticks are blood feeders and bioactive compounds in their saliva have a promising therapeutic potential for treatment of some human diseases associated with hemostatic and immunological disorders (Mans, 2005; Hovius et al, 2008; Francischetti, 2010; Štibrániová et al, 2013; Sousa et al, 2015; Bonvin et al, 2016; Chudzinski-Tavassi et al, 2016, 2018; Chmelar et al, 2017; Murfin and Fikrig, 2017; Parizi et al, 2018). Tick salivary glands, a paired organ consisting of acini in grape-like clusters, produce saliva secreted by the feeding tick into the host primarily to enable blood feeding by suppressing local hemostatic and host immune responses (Francischetti et al, 2009; Kazimírová and Štibrániová, 2013; Wikel, 2013; Kotal et al, 2015; Šimo et al, 2017; Nuttall, 2018).…”
Section: Ticks and Pharmacological Properties Of Their Salivamentioning
confidence: 99%